Different expression of BRAFV600E, ALK and PD-L1 in melanoma in children and adolescents: a nationwide retrospective study in Finland in 1990-2014.
CONCLUSIONS: Young melanoma patients had more favorable prognosis and a different staining profile for BRAFV600E, ALK, and PD-L1 in primary tumor than reported in adults. SLNB status was not an indicator for survival. BRAFV600E-positive patients have worse prognosis and could benefit from surveillance and treatment similarly to adults.
PMID: 32815748 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Rousi EK, Koskivuo IO, Juteau SM, Talve LAI, Hernberg MM, Vihinen PP, Kähäri VM Tags: Acta Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Children | Databases & Libraries | Finland Health | Melanoma | Pathology | Pediatrics | Skin Cancer | Study